| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/0270-9139(95)90615-0 |
| P698 | PubMed publication ID | 7557857 |
| P50 | author | Yun-Fan Liaw | Q59383799 |
| P433 | issue | 4 Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 1101-1108 | |
| P577 | publication date | 1995-10-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Role of hepatitis C virus in dual and triple hepatitis virus infection | |
| P478 | volume | 22 |
| Q28299722 | A comparative review of HLA associations with hepatitis B and C viral infections across global populations |
| Q34474056 | A novel multiplex real-time PCR assay for the concurrent detection of hepatitis A, B and C viruses in patients with acute hepatitis. |
| Q60955480 | A scoring system to predict HBsAg seroclearance in hepatitis B and C coinfected patients treated with interferon and ribavirin in an Asian cohort |
| Q27477956 | Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV |
| Q42995687 | Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses |
| Q30485092 | An overview of triple infection with hepatitis B, C and D viruses |
| Q36135493 | Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update |
| Q43047439 | Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease. |
| Q40291207 | Causal Mediation Analysis of Survival Outcome with Multiple Mediators |
| Q35833159 | Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus |
| Q37205209 | Clinical outcomes of delayed clearance of serum HBsAG in patients with chronic HBV infection |
| Q45474114 | Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection |
| Q45736773 | Concurrent hepatitis B and C virus infection: Is hepatitis C virus stronger? |
| Q43040340 | Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission |
| Q34502980 | Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony |
| Q41667359 | Current therapeutic trends in therapy for chronic viral hepatitis |
| Q37278249 | Current therapy for hepatitis C or D or immunodeficiency virus concurrent infection with chronic hepatitis B. |
| Q30433630 | Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt. |
| Q36220953 | HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study |
| Q30311865 | HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1 |
| Q34485074 | Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection |
| Q34404975 | Hepatitis B virus and hepatitis C virus dual infection |
| Q37132382 | Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment |
| Q35072187 | Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy |
| Q27485700 | High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence |
| Q42989951 | Histological changes of concurrent hepatitis C virus infection in asymptomatic hepatitis B virus patients |
| Q41574253 | Histopathology and detection of hepatitis C virus in liver |
| Q41667261 | Histopathology and pathobiology of hepatotropic virus-induced liver injury |
| Q43032316 | Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection |
| Q34425267 | Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo |
| Q42998247 | Interaction between hepatitis B and C viruses in hepatocellular carcinogenesis |
| Q26752475 | KASL clinical practice guidelines: management of chronic hepatitis B |
| Q27480882 | Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses |
| Q36920164 | Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C |
| Q44195400 | Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. |
| Q40823860 | Mediation effect of hepatitis B and C on mortality. |
| Q37281927 | MicroRNA-122 as a predictor of HBsAg seroclearance in hepatitis B and C dual infected patients treated with interferon and ribavirin |
| Q42995510 | Molecular epidemiology of hepatitis C infection in U.S. veteran liver transplant recipients: evidence for decreasing relative prevalence of genotype 1B. |
| Q27686923 | Molecular mechanisms underlying occult hepatitis B virus infection |
| Q35094277 | Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand |
| Q24815355 | Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection |
| Q34282823 | New animal models of hepatitis B and C. |
| Q34785204 | Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma |
| Q34703532 | Occult hepatitis B virus infection and its clinical implications |
| Q28608449 | Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study |
| Q51761924 | Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C. |
| Q43100447 | Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: Follow-up after a possible breach in hemodialysis machines |
| Q45749810 | Progression of the proportion of hepatitis B virus precore stop mutant following acute superinfection of hepatitis C. |
| Q35231658 | Reduced antibody reactivity to hepatitis C virus antigens in hemodialysis patients coinfected with hepatitis B virus |
| Q35122644 | Regulatory mechanisms of viral hepatitis B and C |
| Q35035182 | Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci in a Chinese population |
| Q42997739 | Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections |
| Q27472767 | SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function |
| Q35821446 | Seroprevalence of the Hepatitis B, Hepatitis C, and Human Immunodeficiency Viruses and Treponema pallidum at the Beijing General Hospital from 2010 to 2014: A Cross-Sectional Study |
| Q42110866 | Serum alpha-fetoprotein level is higher in hepatitis C than hepatitis B infected chronic liver disease patients |
| Q36309219 | Spontaneous viral clearance after 6-21 years of hepatitis B and C viruses coinfection in high HBV endemic area |
| Q38679899 | Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin |
| Q45732241 | Surgical results in patients with hepatitis virus-related hepatocellular carcinoma in Taiwan |
| Q21245094 | The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis |
| Q35354705 | The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre |
| Q45741261 | Treatment of chronic hepatitis B virus infection: who, when, what for and how. |
| Q35207784 | Treatment of hepatitis B in decompensated liver cirrhosis |
| Q42984120 | Viral replication in patients with concomitant hepatitis B and C virus infections |
| Q30439013 | gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection |
Search more.